Tirzepatide 10mg
$99.99
Tirzepatide 10mg is a dual GIP and GLP-1 receptor agonist studied for its ability to regulate glucose levels, suppress appetite, and reduce body weight. It may support advanced metabolic and obesity-related research.
⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.
Description
Tirzepatide 10mg is a synthetic peptide designed as a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This combination has been studied for its enhanced metabolic effects over GLP-1 agonists alone, including improved insulin sensitivity, appetite suppression, and significant body weight reduction in preclinical models.
Tirzepatide mimics the action of two key incretin hormones to promote glucose-dependent insulin secretion, delay gastric emptying, and modulate central appetite-regulating pathways. It is widely researched in models of type 2 diabetes, obesity, and metabolic syndrome.
How Tirzepatide Works (Based on Preclinical Research):
-
Activates both GIP and GLP-1 receptors to enhance insulin response and satiety
-
Reduces food intake and delays gastric emptying
-
Improves glucose regulation and insulin sensitivity
-
Offers superior weight loss outcomes compared to single-pathway agonists
Potential Benefits (Based on Preclinical Research):
-
Significant reductions in body weight and food consumption
-
Improved glycemic control in insulin-resistant models
-
Enhanced lipid metabolism and fat loss
-
Advanced support for obesity and metabolic disorder studies
⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.
Reviews
There are no reviews yet.